His scientific interests lie mostly in microRNA, Neuroblastoma, Cancer research, Genetics and Gene expression. Raymond L. Stallings combines topics linked to Gene silencing with his work on microRNA. Raymond L. Stallings interconnects Hippocampal formation, Status epilepticus and Neuroprotection in the investigation of issues within Gene silencing.
His Neuroblastoma study integrates concerns from other disciplines, such as Cancer, Pediatric cancer, Cellular differentiation, MicroRNA 34a and Regulation of gene expression. His work deals with themes such as Molecular biology, Transcription factor, N-Myc Proto-Oncogene Protein and Gene expression profiling, which intersect with Regulation of gene expression. His Cancer research study incorporates themes from Signal transduction and Pathology.
His primary areas of investigation include Neuroblastoma, Genetics, Cancer research, microRNA and Molecular biology. His Neuroblastoma study combines topics from a wide range of disciplines, such as Cancer, Pediatric cancer, DNA methylation, Bioinformatics and Transcription factor. His Cancer research study also includes fields such as
His microRNA research includes elements of Cell, Gene expression, Cellular differentiation, Regulation of gene expression and Gene silencing. The Gene silencing study combines topics in areas such as Status epilepticus and Neuroprotection. In his study, Cell growth and In vivo is inextricably linked to Cell culture, which falls within the broad field of Molecular biology.
Raymond L. Stallings mainly investigates Neuroblastoma, Cancer research, microRNA, Molecular biology and DNA methylation. His Neuroblastoma study is concerned with the field of Genetics as a whole. The various areas that Raymond L. Stallings examines in his Cancer research study include Promoter, Gene expression, Signal transduction, Phosphorylation and Epigenetics.
He interconnects Viability assay, Cell, Cell culture, Cellular differentiation and Pathology in the investigation of issues within microRNA. His study in Molecular biology is interdisciplinary in nature, drawing from both Gene expression profiling, Carcinogenesis, Transcription factor, Oncogene and Gene silencing. His DNA methylation research integrates issues from Methylation and Massive parallel sequencing.
His main research concerns Neuroblastoma, microRNA, Cancer research, Epilepsy and Molecular biology. His Neuroblastoma study combines topics from a wide range of disciplines, such as Epithelial–mesenchymal transition and Cisplatin. His microRNA research incorporates themes from Apoptosis, Cell and Downregulation and upregulation.
Raymond L. Stallings combines subjects such as DNA methylation, Pathology, Signal transduction, Regulation of gene expression and Epigenetics with his study of Cancer research. His studies in Epilepsy integrate themes in fields like Hippocampus and Gene expression. His Molecular biology research is multidisciplinary, incorporating perspectives in Viability assay and Gene silencing.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
C Welch;Y Chen;R L Stallings.
Evolution and distribution of (GT)n repetitive sequences in mammalian genomes
R.L. Stallings;A.F. Ford;D. Nelson;D.C. Torney.
Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and Apoptosis
Yongxin Chen;Raymond L. Stallings.
Cancer Research (2007)
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
Eva M Jimenez-Mateos;Tobias Engel;Paula Merino-Serrais;Ross C McKiernan.
Nature Medicine (2012)
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner.
Nature Genetics (2012)
Analysis of chromosome breakpoints in neuroblastoma at sub‐kilobase resolution using fine‐tiling oligonucleotide array CGH
Rebecca R. Selzer;Todd A. Richmond;Nathan J. Pofahl;Roland D. Green.
Genes, Chromosomes and Cancer (2005)
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes.
Erin L. Heinzen;Rodney A. Radtke;Thomas J. Urban;Gianpiero L. Cavalleri.
American Journal of Human Genetics (2010)
Human metallothionein genes: structure of the functional locus at 16q13.
A.K. West;R. Stallings;C.E. Hildebrand;R. Chiu.
Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.
Amanda Tivnan;Amanda Tivnan;Wayne Shannon Orr;Wayne Shannon Orr;Vladimir Gubala;Robert Nooney.
PLOS ONE (2012)
miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression
Irene K. Oglesby;Isabella M. Bray;Sanjay H. Chotirmall;Raymond L. Stallings.
Journal of Immunology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: